Marchex (MCHX) Offers Prelim. Q4 Results; Guides Q1, FY12
Tweet
Share
E-mailGet Alerts MCHX Hot Sheet
Price: $1.79 +0.56%
Financial Fact:
General and administrative (1): 5.32M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
General and administrative (1): 5.32M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
In a Form 8-K, Marchex (Nasdaq: MCHX) said it expects to report Q4 sales of $38.8-$39 million, which compares to the Street estimate of $40.56 million.
Sees Q1 sales lower than Q4.
Sees FY12 sales of $150-$160 million, which compares to the Street estimate of $173.03 million.
Sees Q1 sales lower than Q4.
Sees FY12 sales of $150-$160 million, which compares to the Street estimate of $173.03 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
